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Abstract
Background: Interventions to decrease the burden of childhood malnutrition are urgently needed, as millions of
children die annually owing to undernutrition and hundreds of millions more are left cognitively and physically
stunted. Environmental enteric dysfunction (EED), a pervasive chronic subclinical inflammatory condition among
children that develops when complementary foods are introduced, places them at high risk of stunting, malabsorption,
and poor oral vaccine efficacy. Improved interventions to reduce the burden of EED and stunting are expected to
markedly improve the nutritional status and survival of children throughout resource-limited settings.
Methods/Design: We will conduct, in parallel, two prospective randomized controlled clinical trials to determine
whether common beans or cowpeas improve growth, ameliorate EED, and alter the intestinal microbiome during
a high-risk period in the lives of rural Malawian children. Study 1 will enroll children at 6 months of age and
randomize them to receive common beans, cowpeas, or a standard complementary food for 6 months. Anthropometry
will be compared among the three groups; EED will be assessed using a dual-sugar absorption test and by quantifying
human intestinal mRNA for inflammatory messages; and the intestinal microbiota will be characterized by deep
sequencing of fecal DNA, to enumerate host microbial populations and their metabolic capacity. Study 2 will
enroll children 12–23 months old and follow them for 12 months, with similar interventions and assessments as Study 1.
Discussion: By amalgamating the power of rigorous clinical trials and advanced biological analysis, we aim to elucidate
the potential of two grain legumes to reduce stunting and EED in a high-risk population. Legumes have potential as an
affordable and effective complementary food intervention, given their cultural acceptability, nutritional content, and
agricultural feasibility in sub-Saharan Africa.
Trial registration: Clinicaltrials.gov NCT02472262 and NCT02472301.
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Background
Approximately 45 % of all deaths worldwide among
children under the age of five, that is, 3.1 million
deaths annually, are directly or indirectly related to
undernutrition [1]. Additionally, stunting permanently
affects an additional 165 million children worldwide,
and reduces the affected individual’s physical, im-
munological, and cognitive capacity throughout his or
her lifetime. Stunting is estimated to account for
21 % of all disability-adjusted life years in children.
Both stunting and wasting are causally related to the
dietary intake and gut health in children younger than
3 years.
Environmental enteric dysfunction
In developing, impoverished settings, a common gut in-
flammatory condition known as environmental enteric
dysfunction (EED, formerly known as environmental
enteropathy, and even earlier as tropical enteropathy)
develops early in life [2, 3]. While subclinical, EED pre-
disposes children to more clinically manifest forms of
malnutrition: wasting and stunting. Environmental en-
teric dysfunction is characterized by T-cell infiltration of
the intestinal mucosa, leading to a chronic inflammatory
state with increased intestinal permeability, translocation
of gut microbes, micro- and macronutrient malabsorp-
tion, poor weight gain, stunted physical and cognitive
development, frequent enteric infections, and decreased
response to enteric vaccines [4]. While a precise etiology
of EED has not been identified, it is epidemiologically as-
sociated with unsanitary living conditions [5]. Given the
significant contribution of malnutrition to childhood
morbidity and mortality, meaningful progress on redu-
cing EED might establish a lasting foundation for pro-
gress against global hunger [6, 7].
Environmental enteric dysfunction develops within the
first three years of life, a high-risk period marked also by
the transitions from exclusive breastfeeding to mixed
feeding with complementary foods and then to complete
reliance on adult foods for sustenance [6]. In traditional
sub-Saharan African societies, complementary foods are
dominated by monotonous, protein-poor, micronutrient-
poor starches, such as maize, cassava, and sorghum. Al-
ternative, yet culturally acceptable, complementary foods
that can provide a better balance of nutrients might de-
crease EED and improve growth.
Legumes
Legumes provide such an opportunity, as their protein
content is significantly higher than cereals, and they are
rich in dietary fiber, starch, minerals, vitamins, and anti-
oxidants. Common beans and cowpeas, for example,
have 3–4-fold more protein per gram than corn. The
zinc content in legumes is also relatively high and might
further decrease the progression of EED, as we have
demonstrated recently in a prospective randomized trial
[8]. Legumes make an excellent complementary food for
children weaning from exclusive breastfeeding and, with
appropriate preparation, are quite digestible and well-
tolerated [9]. Successful legume–maize blends have, in
fact, already been developed in the past and demon-
strated favorable acceptability profiles in children youn-
ger than one year; they were also nutritionally sound as
a weaning supplement [10].
Additionally, interventions with anti-inflammatory
effects might improve gut health, since EED is a chronic
inflammatory condition, both in the lamina propria of
the intestinal tract and systemically, owing to transloca-
tion of enteric bacteria and their products across the
compromised mucosal border [11]. Simply attacking the
bacterial confounders of EED alone is unlikely to be suf-
ficient, given past failures to improve EED via the use of
probiotics [12] or antibiotics [13]. A growing body of
evidence [14–17] suggests that a diet enriched in le-
gumes decreases markers of inflammation and is corre-
lated with decreases in illnesses with inflammatory
components such as colorectal cancer and cardiovascu-
lar disease [18].
Evidence from molecular and animal models supports
a mechanistic explanation whereby certain legumes may
have direct anti-inflammatory effects on the intestines of
children with EED. For example, the indigestible portion
of common beans downregulates signaling pathways that
lead to inflammation in a mouse model of colon cancer
[19]. Intriguingly, there is probably an essential microbial
component to the downregulation of this inflammatory
cascade: when fermented by normal gut flora, the indi-
gestible fraction from common bean produces short-
chain fatty acids that inhibit colon cancer HT-29 cell
growth and modulates protein expression associated
with apoptosis, cell cycle arrest, and proliferation. These
effects were also demonstrated morphologically [20].
The indigestible fraction of common beans also protects
against chemically induced crypt inflammation in the rat
colon [21, 22].
Cowpeas (Vigna unguiculata) are also attractive for
study, as they grow well in Africa, are culturally ac-
cepted, and are a hardy, drought-tolerant, crop. Cowpeas
also have significant anti-inflammatory effects, mediated
by specific phenolic profiles and antioxidant activity
[23]. These phenolic compounds are also active after
cooking and simulated enzymatic digestion [24].
Microbiome
The evolving intestinal microbiome in African children
also warrants study. Although no specific microbial pop-
ulations or disruptions have yet been linked to EED [25],
evidence suggests that a disruption in the relative
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populations among the four dominant bacterial phyla
(Firmicutes, Bacteroidetes, Actinobacteria, and Proteo-
bacteria) are correlated with gut mucosal breakdown in
inflammatory bowel disease [26, 27]. We have demon-
strated recently that empiric antimicrobial interventions
in severely malnourished children improve nutritional
recovery [28], and that specific disturbances in the mat-
uration of young children’s intestinal microbiota are
linked to severe malnutrition [29]. Hence, it would be
instructive to understand the effect that specific food-
based interventions have on commensal gut organisms
and their metabolic capacity [30]. A recent study com-
paring the gut microbiota in children from rural Burkina
Faso, who consumed a diet rich in legumes, with European
children showed a relative lack of potentially pathogenic
Enterobacteriaceae in the African children, conceivably
protecting these children from severe gut inflammation
and bacterial translocation [31].
Study goals
In our previous work, we have found EED in more than
80 % of children studied in rural Malawi [8, 12, 13, 32].
In these studies, we plan to investigate the effects on
childhood growth, gut health, and the intestinal micro-
biome caused by the systematic introduction of cowpeas




In parallel, we will conduct two prospective, randomized,
investigator-blinded, controlled trials to compare the ef-
fectiveness of legume consumption with the customary
local complementary food on infant and toddler growth
and gut health in rural Malawi. Study 1 will enroll chil-
dren at 5.5–6.5 months of age and provide the random-
ized intervention for 6 months. Study 2 will enroll
children at 12–23 months of age and provide the ran-
domized intervention for 12 months. A probable patient
flow diagram for each trial is shown in Fig. 1.
Study setting
The studies will enroll children in the village clusters
surrounding Limela, Machinga District, and Masenjere,
Nsanje District, Malawi. These villages are populated
primarily by subsistence farmers who grow and consume
maize as their primary staple crop. Water is generally
acquired several times per day from boreholes or nearby
streams. Most homes are quite small and are constructed
from mud bricks and have thatch, or occasionally sheet
metal, roofs. Defecation generally occurs outdoors or in
small pit latrines. Children have frequent contact with
farm animals, such as chickens and goats. Electricity, run-
ning water, and other utilities are invariably absent in
homes. Almost all household chores and child-rearing is
performed by mothers or other female figures; in these
villages, most of the women are illiterate and it is quite
rare for women to have completed primary school.
Ethical considerations
We aim to complete the study using the highest ethical
standards for clinical trials research, in accordance with
the Declaration of Helsinki [33]. Ethical approval has
been obtained from the University of Malawi College
of Medicine Research and Ethics Committee and from
the Human Research Protection Office at Washington
University in St. Louis. Letters of support have also
been obtained from the district health officers in the
two districts where the study will be conducted. Local
village chiefs surrounding the study sites have also
given their consent and support for the studies. Each
child’s caregiver will be briefed on the study proce-
dures and interventions. Verbal and written informed
consent will be obtained from all caregivers. Caregivers
who are unable to sign or write their names will be asked
to document consent using their thumbprints.
Eligibility criteria
Children living within walking distance of one of the
two study sites and within the enrollment ages for the
two studies (5.5–6.5 months for Study 1 or 12–23
months for Study 2) will be screened for eligibility.
Children without severe or moderate acute malnutrition
(defined as a weight-for-height Z score < −2, mid-upper
arm circumference < 12.5, or pitting edema suggestive of
kwashiorkor) and without evidence of congenital or other
chronic diseases will be considered eligible. Additional ex-
clusion criteria will include current treatment for acute
malnutrition and any report from the caregiver that the
child currently has diarrhea. Caregivers who report that
they will be moving away from the study area during the
course of the study (6 months for Study 1 or 12 months
for Study 2) will also be excluded.
Primary outcome measures and sample size
The primary outcome measures of interest will be change
in height-for-age Z score and improvement in the major
biomarker of environmental enteropathy, the lactulose to
mannitol ratio (L:M) [34]. To detect a difference in change
in length of 1.1 cm, which corresponds to a change in
height-for-age Z score of 0.45 units at 12 months of age,
79 children are needed in each group. This sample size
was calculated for a two-tailed test using G*Power 3.1.9.2
[35] at a significance level of 0.05 and 80 % power.
We also desire to detect a (medium) effect size of 0.5
in the L:M test after the legume intervention, again with
80 % power at a significance level of 0.05. Given these
parameters, if the L:M results were to follow a normal
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distribution, thereby allowing the use of Student’s t test
to compare the differences between independent means,
64 children would be needed in each group. If the L:M
results are not normally distributed and require non-
parametric analysis with the Wilcoxon–Mann–Whitney
test, then up to 74 children might be needed per group.
In recent studies, we have experienced approximately a
5 % rate of insufficient urine specimens [8]. We there-
fore very conservatively estimate that this rate might in-
crease to 15–20 %. Thus, we believe that enrolling 300
children with a 15–20 % rate of failure to obtain suffi-
cient urine (owing to dropouts and specimen collection
Fig. 1 Patient flow diagram for each of two clinical trials *Children in Study 1 will be enrolled at 5.5–6.5 months of age and followed for 6 months.
Children in Study 2 will be enrolled at 12–23 months of age and followed for 12 months. **Defined as having a weight-for-height Z score < −2, a mid-
upper-arm circumference < 12.5 cm, or bilateral pitting edema suggestive of kwashiorkor. CSB; corn–soy blend
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failures) will yield complete analysis for at least 240 chil-
dren, or 80 in each group.
Should 100 children indeed be enrolled and retained
in each intervention arm, the power achieved for the
height-for-age Z score criterion is 89 % and for the L:M
criteria is 94 % (if normally distributed) and 93 % (if
non-normally distributied).
Intervention groups
Children in each study will be randomly assigned to re-
ceive common bean flour, cowpea flour, or corn–soy
blended flour in a 1:1:1 ratio across both study sites. The
legume flours will be produced from locally grown and
harvested legumes available in local markets, after sort-
ing to remove rotten beans and any other foreign mate-
rials. After trialing several different methods of cooking
the legumes in small acceptability tests with local chil-
dren, we determined that roasting and milling the beans
into a fine flour to be added to traditional corn porridge
meals was the most palatable and practical method for
introducing these new foods to the diet. Corn–soy
blended flour will be purchased from local suppliers and
caregivers will also be taught to administer this control
intervention in traditional porridge.
Children in Study 1 will receive approximately 40 % of
their daily energy requirements from complementary
feeding (200 kcal/day at 6–8 months of age; 300 kcal/
day at 9–11 months of age) [36] via the intervention
foods (Table 1). Given that the duration and amount of
breastfeeding can be so variable in children after their
first year of life, children in Study 2 will receive approxi-
mately 15–20 % of the estimated total daily energy re-
quirement for nonbreastfed children [37, 38] via the
intervention foods (Table 2).
Choice of legume intervention
The specific intervention legumes thus chosen were
Andean white common beans (Phaseolus vulgaris) and
cowpeas (Vigna unguiculata). The rationale for this
choice was based on several considerations. We felt that
the legumes chosen must be able to be grown widely by
subsistence farmers in sub-Saharan Africa (that is, the
families of children with EED) [39]. Common beans and
cowpeas met this criteria, as they are the most com-
monly grown legumes in Africa. Cowpeas, for example,
grow well in marginal soils that are 85 % sand and less
than 1 % organic matter, as is often found in Africa. As
legumes, both also fix nitrogen in the soil rather than
extracting it.
These two legumes are also good choices since their
nutrient content adds diversity and quality to the habit-
ual African diet, most notably in terms of protein con-
tent. Of course, the legumes chosen must not pose any
significant health risks; common beans do pose a minor
risk with phytohemagglutinin, but are otherwise consid-
ered to be very safe. White common beans were selected
in part because their phytohemagglutinin content is one-
third that of red common beans [40]. The legumes
chosen also support microbiota that produce short-chain
fatty acids or microbiota that are associated with an
anti-inflammatory effect [41, 42].
Preparation of legume flours for consumption
After hand-sorting of the common beans and cowpeas
to remove rotten beans and those infected with weevils,
beans will be roasted in 100 kg batches to an internal
temperature of 120–130 °C for 45–50 minutes. This
serves several purposes: (1) to improve palatability; (2)
to decrease the risk of microbial contamination; and (3)
to decrease the risk of phytohemagglutinin poisoning by
denaturing the toxin found in raw beans. Roasted beans
are then milled into a flour.
Caregivers of children enrolled in the study will be
taught to prepare the flours by mixing the allotted
amount with a small amount of unheated water and mix
with the traditional maize porridge (‘phalla’) that is the
traditional staple complementary food for children of
this age. This porridge is traditionally prepared by add-
ing maize flour to a pot of boiling water and stirring
continuously for 10–15 minutes until the desired
consistency is obtained. By not boiling the intervention
flour, the quantities of nutrients and fibers in the flours
will be unchanged from the amounts measured after
production of the flours. We anticipate that this simple
preparation method will also improve compliance, as
caregivers do not need to cook anything extra for this
Table 1 Quantities and calories of flours to be consumed by subjects enrolled in Study 1




Number of 18 ml
scoops/day
Total amount (kg) per
6-week food distribution
6–8 months 80 21 2 0.88
9–11 months 120 31.5 3 1.32




Number of 18 ml
scoops/day
Total amount (kg) per
6 week food distribution
6–8 months 76 20 2 0.84
9–11 months 114 30 3 1.26
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one child – instead, a small portion of porridge can be
set aside and the assigned intervention flour with water
can be added to the already cooked maize porridge.
Randomization methods and blinding
Block randomization will be employed, using a computer-
generated list in permuted blocks of nine. Allocation
groups will be pre-printed on paper that will be sealed in
opaque envelopes. The caregivers will then each draw out
one opaque envelope, which will be opened in their pres-
ence, to determine their intervention groups.
Each type of flour will be packaged identically, except
for the color of the lid used on the jars that contain the
interventions. The allocation code connecting the lid
colors to the types of flour is known only to the individ-
uals involved in the packaging of the flours. All field re-
search nurses, investigators, and laboratory personnel
will be kept blinded to the color code as well as to each
child’s assigned color throughout the study. Caregivers
will not be told which type of flour they have been
assigned, but while the flours have a very similar appear-
ance and texture, it is reasonable to assume that care-
givers may deduce the type of flour their children has
been assigned by tasting or smelling the flour them-
selves. To reflect this possibility, we thus consider these
to be investigator-blinded studies.
Study participation
After obtaining verbal and written consent from care-
givers of eligible children, randomization will occur and
basic sociodemographic, food frequency, and economic
data will be collected. Recent illnesses during the
previous 7 days will be queried at each visit [43]. At the
initial visit, anthropometric data will be gathered to en-
sure that the child is not acutely malnourished and thus
ineligible for the study. If eligible, the child will continue
with the dual-sugar absorption test and stool collection.
After successful completion of the dual-sugar absorption
test and stool collection, a 6-week supply of the assigned
flour intervention will be provided and the caregiver will
be educated on how to prepare and feed the flour to the
child. The complete schedule of study visits, testing, and
distribution of flours is provided in Table 3 for Study 1
and Table 4 for Study 2.
Anthropometry
Weight will be assessed to the nearest 5 g using standard
digital scales (seca 334, Chino, CA, USA) and height will
be measured to the nearest 0.1 cm using a rigid height
board (seca 417, Chino, CA, USA). Mid-upper-arm cir-
cumference will be measured on each child’s left upper
arm using standard flexible plastic insert tapes to the
nearest 0.1 cm (TALC, St. Albans, UK). Each child will
also be assessed for kwashiorkor by pressing with the
pad of the thumb on the dorsum of the foot and
observing for pitting edema. Any child with a weight-
for-height Z score less than −2, a mid-upper arm
circumference less than 12.5, or pitting edema will be
classified as acutely malnourished [44]. Malnourished
children will be excluded from enrollment in the study
and will instead be treated with ready-to-use lipid-
nutrient spreads according to usual protocols until
they recover [45].
Table 2 Quantities and calories of flours to be consumed be subjects enrolled in Study 2




Number of 18 ml
scoops/day
Total amount (kg) per
6-week food distribution
12–23 months 160 42 4 1.76
24–35 months 200 52.5 5 2.21




Number of 18 ml
scoops/day
Total amount (kg) per
6 week food distribution
12–23 months 152 40 4 1.68
24–35 months 190 50 5 2.1
Table 3 Study participation schedule for subjects enrolled in Study 1
Anthropometry Dual-sugar absorption test Stool collection for EED biomarker
and microbiome studies
Intervention flour distribution
Week 0 X X X X
Week 2 X X
Week 6 X X X
Week 12 X X X X
Week 18 X X X
Week 24 X X X
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Dual-sugar absorption test
The dual-sugar permeability test [34] will be used as a
standard noninvasive measure of gut integrity, as it cor-
relates with the severity of small bowel histological
changes [46], severity of diarrhea [47], micronutrient sta-
tus [48, 49], and growth in weight and length [50]. The
ratio of urinary excretion of lactulose to mannitol is used
to measure intestinal mucosal permeability with higher
ratios indicative of increased intestinal permeability.
To participate in the test, children will be asked to
take no food (water and breast milk are permitted) after
10 p.m. on the previous night. The test begins when
each child drinks a 20 ml solution containing 1 g manni-
tol and 5 g lactulose. Children will be carefully observed
by research assistants to ensure complete ingestion of
this solution; any child who spits up, vomits, or refuses
the solution will be brought back for testing on another
day. Adhesive urine bags will then be placed on the
child’s perineum and monitored for urine output. As
soon as urine is noted in the bag, it will be removed and
the urine transferred to a clean container containing
10 mg merthiolate to prevent bacterial degradation of
the excreted sugars, and a new bag will be placed. After
3–3.5 hours, children will be given water to drink to fa-
cilitate the collection of urine. After the child voids for
the first time after 4 hours, the urine collection will be
omplete. The total amount of urine voided during the
study will then be quantified and an aliquot flash frozen
for analysis.
The concentrations of lactulose and mannitol in the
total voided urine will be determined using HPLC, as
described previously [51]. Given a recent report that
HPLC is less reliable than liquid chromatography-
tandem mass spectrometry [52], we previously com-
pared our L:M results by HPLC on 115 samples with
those obtained by the Mayo Clinic performed using
liquid chromatography-tandem mass spectrometry and
we found the results to be highly correlated (data not
shown). The concentrations of these sugars in the
urine will then be multiplied by the total amount of
urine voided to provide a measure of the total
amount of these sugars voided. The ratio of the
sugars voided in the urine, as well as the amount
voided as a percentage of the amount ingested, will
be computed and compared between groups.
Exploratory analysis of EED biomarkers in fecal samples
Stool samples will be collected using plastic-lined di-
apers and aliquots of stool transferred using sterile
metal spatulas into cryovials and flash frozen in li-
quid nitrogen within five minutes of defecation.
Novel fecal biomarkers will be sought to assess bowel
integrity and levels of inflammation noninvasively.
Evaluation of these markers of barrier dysfunction
might pave the way for assessment of intestinal mu-
cosal permeability and inflammatory response in
diagnosing the degree and progression of EED in vul-
nerable populations without the need for the rela-
tively lengthy and cumbersome dual-sugar absorption
test [53–61]. Markers of interest include cytokines,
interleukins, immunoglobulins, REG1A, REG1B, cal-
protectin, and zonulin.
We also plan to continue our exploration of human
mRNA transcripts of putative inflammatory and anti-
microbial mediators that are upregulated in EED and
found in fecal samples. Nucleic acids are first extracted
using a NucliSens EasyMAG kit (BioMérieux), which is
a bead-based RNA-specific method. A digital droplet
PCR is used to detect low copy numbers of human
mRNA reliably [62]. The digital droplet PCR is unique
in that after the PCR is set up in the aqueous phase, the
reaction is emulsified in oil, creating 20,000 aqueous
bubbles that are counted by laser for positive fluores-
cence of the probe of interest. The quantities of mRNA
in a given sample are normalized to a housekeeping gene
Table 4 Study participation schedule for subjects enrolled in Study 2
Anthropometry Dual-sugar absorption test Stool collection for EED biomarker
and microbiome studies
Intervention flour distribution
Week 0 X X X X
Week 2 X X
Week 6 X X X
Week 12 X X X X
Week 18 X X
Week 24 X X X X
Week 30 X X
Week 36 X X X X
Week 42 X X
Week 48 X X X
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present in abundant quantities. A number of promising
targets that correlate with EED have already been identi-
fied (unpublished data) and these will be pursued further
in this study, with the aim of identifying one or more
that may serve as less cumbersome biomarkers of EED.
Newer whole human transcriptome microarray tech-
nology [63, 64] will also be employed to interrogate
these samples, as another approach to identify these
biomarkers.
Microbiome analysis
To investigate correlations between bacterial populations
in the gut and EED, as well as the effects of the legume
interventions on gut microbe populations, bacterial gen-
omic DNA will be prepared separately from fecal sam-
ples obtained from study children. To prepare the stool
samples for sequencing, genomic DNA will be extracted
using standard protocols (http://hmpdacc.org/resources/
tools_protocols.php) V1-V3 variable regions of bacterial
16S rRNA genes will be amplified by PCR and the
resulting amplicons will be subjected to high throughput
sequencing. We will use the to Illumina Miseq platform
for targeted 16S rRNA sequencing. This deep sequen-
cing permits the recognition of rare members of the
microbiota that may be shared or that may discriminate
these human populations. 16S rRNA sequences will be
processed through the pipeline developed by human
microbiome projects at The Genome Institute at Wash-
ington University. In brief, quality trimming, denosing
and chimera removal will be performed to yield high qual-
ity reads [65]. Reads passing the above filtering steps will
be classified from the phylum to the genus level using an
automated implementation of the Ribosomal Database
Project’s Classifier [66]. Species-level bacterial phylotypes
will be defined as organisms sharing at least 97 % nucleo-
tide sequence identity in the V1-V3 regions of their 16S
rRNA genes using the Mothur software package [67].
Shotgun sequencing will be performed to examine the
taxa that are prominently represented in the infant
microbiome but inefficiently captured by PCR primers
designed to target other variable regions. Whole genome
sequencing libraries will be prepared following a stand-
ard protocol from Illumina. Ten GB 100 bp pair-end
reads per sample will be sequenced on the Illumina
HiSeq platform. Reads passing quality filtering and hu-
man contamination removal will be classified to species
level based on nucleotide sequence alignment to refer-
ence genomes using Real Time Genomics map software
(Real Time Genomics, San Bruno, CA, USA). Read map-
ping results will be transformed to values representing
the coverage of each reference genome using refcov
software (http://gmt.genome.wustl.edu/packages/refcov/
index.html). The coverage values are then scaled to a
million aligned reads to calculate ‘depth of coverage per
million reads’ values. Taxa-based analysis will be the
same as the 16S rRNA genes approach described above.
Data management and analysis
Clinical data such as anthropometry, demography, and
morbidity data, will be collected on standardized forms
by field workers. Field workers will be trained and vali-
dated with the questionnaires and measurements they
collect prior to data collection. Anthropometric Z-scores
will be calculated from the 2006 WHO Multicentre
Growth Reference Survey [68]. Data will be double-
entered into a password-protected Microsoft Access
database by research assistants blinded to food assign-
ments. All discrepancies will be resolved by examination
of the original data cards and discussion with the rele-
vant field workers, possibly including repeat examination
of the child and questioning of the caregiver as needed.
Once all values are entered and discrepancies resolved,
the data set will be locked.
Comparisons will be made between cowpea flour and
corn–soy blended flour, separately from common beans
and corn–soy blend. Fisher’s exact test will generally be
used to compare discrete parameters, and Student’s t
test will be used for continuous parameters. A difference
with P < 0.05 will be considered statistically significant.
These statistical methods will also be used for all clinical
data and EED measures (e.g., L:M ratio), which are con-
tinuous measures of EED status.
The microbiome data analyses and interpretation re-
quire specialized tools. Read-based metabolic profiling of
the microbial communities is performed by first using
whole genome sequencing reads from each sample to
probe the Kyoto Encyclopedia of Genes and Genomes
using Mblastx (MultiCoreWare, St. Louis, MO) and then
search results are run through the metabolic pathway
pipeline developed as part of the Human Microbiome
Project to obtain enzyme and pathway abundance and
coverage from metagenomic communities. Differentially
expressed enzymes and pathways between groups (both
between intervention groups as well as within the same
individual, for example before and after intervention) are
identified using LEfSe (http://huttenhower.sph.harvard.edu/
lefse). Principal component analysis will be performed
to identify cluster patterns based on the gene content
and metabolic pathway abundance between the legume
and corn–soy blend groups.
All microbiome data will be rarefied to ensure the
sample comparisons are at the same read depth. Ordin-
ation methods will facilitate the pattern analysis of the
high dimensional microbiome data by reducing its di-
mensionality to 2–3 dimensions, such that the original
distance between the samples is preserved to a large de-
gree. In particular, principal component analysis with
Bray–Curtis dissimilarity will be used to identify the
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sample cluster pattern based on the microbial commu-
nity structures.
A robust statistical approach that is widely used in
ecology and metagenomics, Permutational Multivariate
Analysis of Variance (perMANOVA in the R software
package, http://www.r-project.org), will be used to test
the significance of differences at the whole bacterial
community level between two or more groups. Dissimi-
larity matrices will be generated based on the taxon
abundance table, and will be treated as the dependent
variable in the model. We will use metastats, a program
developed in the Human Microbiome Project, to detect
differentially abundant taxa between groups [69]. The
statistical tests will be corrected for false discovery rates
using the q-values approach, an approach that has been
effectively applied in metagenomic studies for identify-
ing the taxa of interest. Indices such as richness (the
total different number of taxa) and Shannon diversity
(the number of taxa present as well as the relative
abundances) that categorize the complexity of the bac-
teria community will be computed. Student’s t-test will
be used to compare the diversity differences between
groups.
Discussion
Childhood undernutrition remains a formidable challenge
in global health, contributing greatly to the continued un-
acceptably high rates of mortality among young children,
and even more so to decreased achievement of full adult
cognitive and physical growth potential [70]. No signifi-
cant reduction in the overall damage caused by undernu-
trition is likely to be successful without making major
inroads against EED and stunting [4, 71], especially since
the two have a synergistic detrimental effect [72, 73]. We
have presented here the outlines of two randomized
investigator-blinded prospective controlled clinical trials
to test the hypothesis that dietary supplementation with
legumes at times of peak vulnerability in child growth and
development will decrease EED and stunting.
Prior studies using pharmacological interventions to
reduce EED have only shown relatively modest and
transient improvements in gut health and it remains
unclear whether any such intervention targeting in-
flammation will be effective in reducing EED [74]. In-
deed it is quite possible that sanitation and hygiene
interventions may be the most effective interventions
to ameliorate EED and stunting [5, 75], but the ex-
tremely high cost and logistical challenges of imple-
menting such interventions throughout the developing
world unfortunately remain exceedingly high.
The trials presented here are novel in that we have
taken a food-based approach to targeting EED [11], care-
fully selecting two legumes – common beans and
cowpeas – that have high levels of both macronutrients
and micronutrients that make them appealing choices as
complementary foods. We also postulate that their anti-
inflammatory effects in the gut may also help to de-
crease the chronic inflammatory state that accompanies
EED [73] and stunting [76].
Beans have been cultivated for more than 700 years
and were harvested in Africa long before the colonial
era. They might thus serve as major sources of protein
in southeast Africa if proven to be of benefit in these
young children. Indeed, the Great Lakes region of Africa
has the highest per capita bean consumption in the
world, demonstrating the cultural acceptability of such
legumes in our target population [77]. However, the con-
sumption of legumes among young children in rural
Malawi remains extremely low due to the preference for
maize and other carbohydrate-rich staples [78]. Legumes
could therefore serve as a complementary food in this
high-risk population, with key measurable endpoints and
biomarkers, including markers of EED and growth
parameters.
One limitation of the study is the lack of complete
blinding of the assigned flour interventions between
the three groups. Although the different flours will be
packaged similarly and, at first pass, have very similar
appearances and textures, a curious caregiver could
ultimately determine the nature of the intervention by
taste and/or smell, and subsequently trade their
assigned intervention with another participant from
the same village. We are optimistic that this will be a
relatively unlikely occurrence, as our past research
into this possibility in a very similar population did
not demonstrate any evidence of sharing or trading
either assigned food [79] or pharmacological [28] in-
terventions. Extensive education of caregivers of trial
participants (virtually all of whom will be the house-
hold matriarch) and community engagement with vil-
lage leaders about the need to comply with the
assigned interventions should also decrease this possi-
bility. Our preliminary data from acceptability studies
did not demonstrate that the children themselves did
not like the flours, and thus they will not likely be
the motivation for any trading either.
The possibility of sharing of the flours with other
members in the household also exists, but this should be
relatively even across the three different intervention
arms, and relatively unlikely since the amount of flour to
be consumed each day is rather small and unlikely to be
particularly satisfying to a hungry family member.
As the trials get underway, we may also use this robust
study design and multi-site enrollment of two unique
age groups with a presumed range of pathology to con-
sider the addition of sub-studies to explore concepts
such as household food consumption, cognitive and
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physical development, serum or other functional bio-
markers of nutritional status, and other health variables
such as acute infectious symptoms.
Trial status
Recruitment of trial participants began in July 2015.
Interaction with study subjects is expected to last ap-
proximately 18 months.
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